| 1 |
33376542 | Inhibition of autophagy enhances apoptosis induced by bortezomib in AML cells. | 2021 Feb |
1 |
| 2 |
33609728 | Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib. | 2021 May 23 |
1 |
| 3 |
32551032 | BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis. | 2020 |
1 |
| 4 |
32868799 | Alpha-lipoic acid alters the antitumor effect of bortezomib in melanoma cells in vitro. | 2020 Aug 31 |
1 |
| 5 |
33191863 | Blockade of PLD1 potentiates the antitumor effects of bortezomib in multiple myeloma cells by inhibiting the mTOR/NF-κB signal pathway. | 2020 Dec |
1 |
| 6 |
31392596 | G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis. | 2019 Sep |
1 |
| 7 |
31631595 | [Bortezomib Inhibits Extranodal Natural Killer/T Cell Lymphoma, Nasal Type by Targeting NF-κB Signaling Pathway]. | 2019 May |
1 |
| 8 |
29349597 | Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis. | 2018 Aug |
1 |
| 9 |
30338762 | Cobalt chloride affects the death of SH-SY5Y cells induced by inhibition of ubiquitin proteasome system. Role of heat shock protein 70 and caspase 3. | 2018 Oct 19 |
1 |
| 10 |
28487980 | Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia. | 2017 Jul |
1 |
| 11 |
28725954 | Proteasome Stress Triggers Death of SH-SY5Y and T98G Cells via Different Cellular Mechanisms. | 2017 Nov |
2 |
| 12 |
28869453 | Bortezomib could down-regulate the expression of RANKL, inhibit cell proliferation and induce cell apoptosis in the human myeloma cell line RPMI 8226 by activating casepase-3. | 2017 Aug 23 |
2 |
| 13 |
29070119 | [Anti-proliferation Effect of NS-398 in Combination with Bortezomib on Multiple Myeloma RPMI 8226 Cells In Vitro]. | 2017 Oct |
1 |
| 14 |
29161153 | Protective effects of agomelatine on testicular damage caused by bortezomib. | 2017 |
1 |
| 15 |
27863383 | Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy. | 2016 Dec 27 |
1 |
| 16 |
27995884 | [Study of the effects in vitro of berberine combined with bortezomib on multiple myeloma cell line U266 cells]. | 2016 Nov 14 |
1 |
| 17 |
25367763 | Differential impact of bortezomib on HL-60 and K562 cells. | 2015 Jan |
1 |
| 18 |
25602436 | Bortezomib inhibits gastric carcinoma HGC-27 cells through the phospho-Jun N-terminal kinase (p-JNK) pathway in vitro. | 2015 Apr 1 |
1 |
| 19 |
25812695 | Mcl-1 downregulation sensitizes glioma to bortezomib-induced apoptosis. | 2015 May |
1 |
| 20 |
25995634 | Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe3O4 magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells. | 2015 |
1 |
| 21 |
26165741 | Dissociation of E-cadherin/β-catenin complex by MG132 and bortezomib enhances CDDP induced cell death in oral cancer SCC-25 cells. | 2015 Dec |
1 |
| 22 |
26171069 | Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells. | 2015 Jul |
2 |
| 23 |
26254608 | The proapoptotic protein Bim is up regulated by 1α,25-dihydroxyvitamin D3 and its receptor agonist in endothelial cells and transformed by viral GPCR associated to Kaposi sarcoma. | 2015 Oct |
1 |
| 24 |
26544558 | Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis. | 2015 |
1 |
| 25 |
26622468 | Bortezomib inhibits cell proliferation in prostate cancer. | 2015 Sep |
1 |
| 26 |
24706190 | Suitable drug combination with bortezomib for multiple myeloma under stroma-free conditions and in contact with fibronectin or bone marrow stromal cells. | 2014 Jun |
1 |
| 27 |
24854658 | Apoptotic effects of proteasome and histone deacetylase inhibitors in prostate cancer cell lines. | 2014 May 9 |
1 |
| 28 |
25323693 | Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity. | 2014 Nov |
2 |
| 29 |
23025401 | Changes in protein profiles of multiple myeloma cells in response to bortezomib. | 2013 May |
1 |
| 30 |
23079083 | Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells. | 2013 Jan |
2 |
| 31 |
23698252 | Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells. | 2013 Jul |
1 |
| 32 |
24093630 | Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis. | 2013 Dec |
2 |
| 33 |
24155950 | Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells. | 2013 |
1 |
| 34 |
24156429 | [Effect of PCI-32765 and bortezomib on proliferation and apoptosis of B-cell tumor cell lines and its mechanisms]. | 2013 Oct |
1 |
| 35 |
24377552 | Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells. | 2013 |
1 |
| 36 |
21978467 | Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy. | 2012 Feb |
1 |
| 37 |
22006286 | Targeting the proteasome as a promising therapeutic strategy in thyroid cancer. | 2012 Mar 15 |
1 |
| 38 |
22262760 | Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma. | 2012 Mar 15 |
1 |
| 39 |
22313636 | Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitor. | 2012 Apr |
1 |
| 40 |
22391178 | Effects of arsenic trioxide combined with bortezomib on apoptosis of multiple myeloma cell line KM3 and its mechanisms. | 2012 Feb |
3 |
| 41 |
22436457 | Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma. | 2012 Mar 21 |
1 |
| 42 |
22477151 | Combined inhibition of cellular pathways as a future therapeutic option in fatal anaplastic thyroid cancer. | 2012 Dec |
1 |
| 43 |
22739154 | [Effect of bortezomib and low concentration cytarabine on apoptosis in U937 cell line]. | 2012 Jun |
1 |
| 44 |
21174067 | Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress. | 2011 Mar |
2 |
| 45 |
21195056 | Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl+ cells sensitive and resistant to STI571 through down-regulation Mcl-1. | 2011 Feb 4 |
1 |
| 46 |
21448923 | Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli. | 2011 Nov |
1 |
| 47 |
21518486 | [NB4 cell apoptosis induced by bortezomib combined with As(2)O(3) and its mechanism]. | 2011 Apr |
3 |
| 48 |
19800672 | Proteasome inhibitor bortezomib increases radiation sensitivity in androgen independent human prostate cancer cells. | 2010 Apr |
1 |
| 49 |
20150630 | The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors in vitro. | 2010 Jan |
1 |
| 50 |
20378569 | Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells. | 2010 Sep |
1 |